(1mg) Repaglinide , (0.3mg) Voglibose ''''"

Introduction

RAPIGLINIDE VOG 1.0 is an advanced oral antidiabetic formulation containing Repaglinide 1 mg and Voglibose 0.3 mg, designed to offer dual mechanism control over both fasting and postprandial blood glucose levels in patients with type 2 diabetes mellitus (T2DM).

Manufactured by Steris Healthcare Pvt Ltd, this combination is particularly effective in patients with high post-meal sugar spikes, early-stage diabetes, or those who are not adequately controlled by monotherapy.

Composition Overview

1. Repaglinide (1 mg): A meglitinide-class insulin secretagogue that stimulates the pancreas to release insulin quickly in response to a meal.

2. Voglibose (0.3 mg): An alpha-glucosidase inhibitor that slows the digestion and absorption of carbohydrates in the intestine, thus reducing postprandial glucose surges.

RAPIGLINIDE VOG 1.0 Tablet Uses

This tablet is primarily used for:

• Management of Type 2 Diabetes Mellitus (T2DM)

• Postprandial hyperglycemia (PPHG)

• As first-line or add-on therapy in early and moderately uncontrolled diabetes

• Patients who need targeted control for meal-related glucose spikes

Especially beneficial in patients with irregular eating habits and carbohydrate-rich diets.

How RAPIGLINIDE VOG 1.0 Works – Mechanism of Action

Repaglinide:

• Stimulates rapid, short-acting insulin secretion from pancreatic beta-cells

• Helps in quick control of glucose rise after meals

• Acts within 30 minutes, peaks at 1–1.5 hours, and clears in 4–6 hours

Voglibose:

• Inhibits alpha-glucosidase in the small intestine

• Delays carbohydrate digestion and glucose absorption

• Minimizes post-meal sugar surges without increasing insulin levels

The combination offers a synergistic effect, addressing both insulin secretion and glucose absorption.

Dosage and Administration

• Typical Adult Dose: 1 tablet of RAPIGLINIDE VOG 1.0 before each main meal

• Route: Oral

• Frequency: Usually two to three times daily, depending on meal frequency

Important: Must be taken just before a meal. If a meal is skipped, skip the dose.

Benefits of RAPIGLINIDE VOG 1.0

• Dual action: Boosts insulin + slows carb absorption

• Targets postprandial hyperglycemia, a major contributor to HbA1c

• Rapid onset of action mimics natural insulin release

• Low risk of prolonged hypoglycemia

• Convenient dosing around meals

• Suitable for early intervention in type 2 diabetes

Side Effects

Common Side Effects:

• Mild hypoglycemia (especially if meal is skipped)

• Flatulence, abdominal bloating (due to Voglibose)

• Nausea or mild gastrointestinal upset

Rare but Serious:

• Liver enzyme elevation (monitor LFTs periodically)

• Severe hypoglycemia when overdosed or combined with other insulin secretagogues

Most side effects are mild and manageable with dose adjustment.

Precautions and Warnings

• Not recommended in type 1 diabetes

• Avoid in pregnant or lactating women unless advised

• Not suitable for patients with severe liver dysfunction

• Monitor blood glucose levels regularly

• Dose adjustments may be required in elderly or renal impaired individuals

Drug Interactions

• Gemfibrozil, ketoconazole, and rifampicin can affect repaglinide metabolism

• Can interact with beta-blockers, NSAIDs, and diuretics

• Avoid with digestive enzyme supplements when taking Voglibose

Storage

• Store in a cool, dry place below 25°C

• Protect from light and moisture

• Keep out of reach of children

Price and Availability

RAPIGLINIDE VOG 1.0 is affordably priced by Steris Healthcare Pvt Ltd to ensure wide accessibility. It is available through authorized chemists, hospitals, and Steris Healthcare’s official medical supply partners across India.

Why Choose RAPIGLINIDE VOG 1.0 by Steris Healthcare?

• High-quality dual therapy from WHO-GMP certified facilities

• Well-researched, physician-trusted formulation

• Ideal for postprandial glucose control

• Strong distribution network for consistent availability

• Competitive pricing to support long-term diabetes management

FAQs – RAPIGLINIDE VOG 1.0

Q1. What is RAPIGLINIDE VOG 1.0 used for?

RAPIGLINIDE VOG 1.0 is used to treat type 2 diabetes, especially for controlling post-meal blood sugar spikes.

Q2. When should I take RAPIGLINIDE VOG 1.0?

Take the tablet immediately before a meal. Do not take it if you're skipping the meal.

Q3. Can RAPIGLINIDE VOG 1.0 cause hypoglycemia?

It may cause mild hypoglycemia, especially if meals are delayed or skipped. Always eat on time.

Q4. Can I use RAPIGLINIDE VOG 1.0 with Metformin?

Yes, it can be combined with Metformin or other oral antidiabetic drugs under medical supervision.

Q5. Is it safe for elderly patients?

Yes, but the dose may need adjustment. Regular monitoring is essential.

Q6. Where can I buy RAPIGLINIDE VOG 1.0 in India?

You can purchase it from certified medical stores or Steris Healthcare’s trusted distribution network, known for quality and reliability.

Conclusion

RAPIGLINIDE VOG 1.0 is an intelligent combination therapy for patients struggling with post-meal glucose control, offering a dual mechanism approach to lower blood sugar effectively. With its rapid insulin stimulation and delayed glucose absorption, it provides comprehensive coverage for glycemic spikes in type 2 diabetes patients.

Choose RAPIGLINIDE VOG 1.0 – Fast Action. Smooth Control. Trusted Care.